# Anranfei (Kunshan) New Drug Development

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anranfei-kunshan-new-drug-development

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Angel (Apr 17, 2025)
- Investors on record: 1

## About

Based in Kunshan, China, and founded in 2023, Anranfei (Kunshan) New Drug Development is a biotechnology company engaged in human genetic diagnosis and treatment technology. In July 2023, Anranfei (Kunshan) New Drug Development raised strategic investment funding from new investor Frees Fund.

The company is committed to the development of human genetic diagnosis and treatment technology, medical research and experimental development, health consulting services, etc.

## Funding rounds

- Angel, Apr 17, 2025 — Frees Fund

## Investors

- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Angel